CD38 and acute myeloid leukemia: Consistent with the loss of the CD34 + /CD38 − fraction, an increased proportion of cells expressing the monocytic differentiation marker CD11b was observed after DS-1594a·succinate in AML#8531, AML676 and NCCHD010 cells (Fig. 3B and Additional file 1: Figure S3B).